<DOC>
	<DOCNO>NCT00941369</DOCNO>
	<brief_summary>Primary Objective : To investigate impact insulin glargine versus Neutral Protamine Hagedorn basal insulin composite diabetes relate quality life score ( DRQoL ) . Secondary Objective : A comparison combination therapy insulin glargine versus Neutral Protamine Hagedorn basal insulin baseline endpoint term : - Glycaemic parameter : 7 blood glucose profile - Incidence confirm symptomatic hypoglycemia well confirm severe hypoglycemia - Change lipid status</brief_summary>
	<brief_title>Health Assessment , Patient Treatment Satisfaction Quality-of-Life Insulin-Naive Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>Inclusion criterion : Patients type 2 diabetes mellitus ( history ketoacidosis ) accord ADA criterion . Treatment combination maximum 2 substance class stable dosage last 3 month : metformin and/or sulfonylurea . No pretreatment insulin last 3 month study . Glycated Haemoglobin A1c ( HbA1c ) value &gt; = 7.0 &gt; = 9.5 % Fasting Blood Glucose ( FBG ) &gt; = 120 mg/dl ( 6.7 mmol/l ) . Body mass index &lt; 40 kg/m . Ability read understand German language . Ability willingness follow tight antidiabetic therapy perform blood glucose self monitoring regular basis . Women childbearing potential take adequate contraceptive protection . Exclusion criterion : Patients type 1 diabetes mellitus . Any history ketoacidosis . Pregnancy . Prior treatment insulin . Treatment two oral agent within last 3 month continuous treatment thiazolidinediones , GLP1 receptor agonist DipeptidylPeptidase IV ( DPPIV ) inhibitor . History drug alcohol abuse . Diabetic retinopathy surgical treatment ( laser photocoagulation vitrectomy ) last 3 month prior study entry may require surgical treatment within 3 month study entry . Following pancreatectomy . Impaired hepatic function . Impaired renal function . Mental condition render patient unable understand nature , scope possible consequence study . Evidence uncooperative attitude , include poor compliance ( antidiabetic ) treatment . Inability attend followup visit . Current treatment mental disorder accord ICD 10 ( F 5 Diagnoses ) . Patients relationship dependance investigator ( ) and/or sponsor . Systemic corticoid &gt; 7,5 mg prednisolon equivalent &lt; or=7,5 mg prednisolon equivalent le 2 month . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>